PKN.F PerkinElmer Inc

Healthcare Biotechnology Frankfurt Exchange
139.15 EUR
Close of Nov 13, 2026
69.56 152.10
Market cap
EUR 15.5B
P/E
71.7x
P/B
2.46x
ROE
2.8%
Dividend yield
0.17%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PKN.F undervalued?

Graham number
Price139.15
Graham value49.67
Premium180.2%

PKN.F trades 180.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PerkinElmer Inc fundamental analysis

No fundamental analysis for PerkinElmer Inc yet.

PerkinElmer Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for …

Full company profile